Comments
GlaxoSmithKline Pharmaceuticals today reported 3.45 per cent rise in standalone net profit at Rs 98.85 crore for the second quarter ended September 30, 2017.
It had posted a net profit of Rs 95.55 crore for the July-September period of the previous fiscal, GSK Pharma said in a BSE filing.
Standalone total income from the operations also rose to Rs 799.12 crore for the quarter under review against Rs 717.53 crore in the same period a year ago.
GSK Pharma stock ended down by 0.65 per cent at Rs 2,901.35.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.